| BSE Code | Company | Start Date | Purpose |
|---|---|---|---|
| 526349 | Craftroot Retail Craftroot Retail Ltd | 10-Aug-2026 | Craftroot Retail Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June 2026 along with the Auditors Limited Review Report. |
| 526081 | SC Agrotech SC Agrotech Ltd | 10-Aug-2026 | SC Agrotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve 1. To consider and approve unaudited financial results of the company for the period ended on June 30 2026. 2. Any other business matter with the permission of the Chair. |
| 524440 | Camex Camex Ltd | 10-Aug-2026 | Camex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve 1. To consider and approve the Un-Audited Financial Results for the Quarter ended on June 30 2026 as per IND-AS alongwith Limited Review Report to be issued by Statutory Auditors of the Company in pursuance of Regulation 33 of SEBI (LODR) Regulation 2015. 2. Any other Business with the approval of Board of Directors. |
| 524614 | IEL IEL Ltd | 10-Aug-2026 | IEL Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve 1. Un-Audited Standalone Financial Results of the Company for the Quarter ended 30th June 2026. 2. Any other matter with the permission of Chair. |
| 524624 | Gagan Gases Gagan Gases Ltd | 10-Aug-2026 | Gagan Gases Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve 1. To take on record the Unaudited financial results for the quarter ended on 30.06.2026. 2. To consider and approve the Director's report for the year 2025-26 and Secretarial Audit report. 3 .To fix the date of share transfer book closing. 4. To appoint scrutinizer for AGM. 5 .To appoint statutory auditors. 6. To fix the date, time, place and agenda for the 40th AGM of the members of the company. 7.Any other matter with the permission of the chair. |
| 524632 | Shukra Pharma. Shukra Pharmaceuticals Ltd | 11-Aug-2026 | Shukra Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve To consider and approve Unaudited financial result for the Quarter ended on 30th June 2026 along with the Auditors Limited Review Report. |
| 524703 | Sandu Pharma. Sandu Pharmaceuticals Ltd | 11-Aug-2026 | Sandu Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1.To consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended 30th June 2026. 2.To consider any other matter with the permission of the Chair |
| 524727 | Span Divergent Span Divergent Ltd | 11-Aug-2026 | Span Divergent Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve 1. The un audited Standalone and consolidated Financial Results of the Company for the quarter ended on June 30 2026. 2. Other items of agenda |
| 524504 | Revati Media Revati Media Ltd | 11-Aug-2026 | Revati Media Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve a) To consider and approve the Audited Financial Results for the Quarter ended 30th June 2026; b) Any other business with the permission of chair |
| 526125 | BN Agrochem BN Agrochem Ltd | 11-Aug-2026 | BN Agrochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the first quarter ended June 30 2026 along with the Limited Review Report of the Auditors for the corresponding period. |



